Latest news with #NAD
Yahoo
2 hours ago
- Business
- Yahoo
National Advertising Division Recommends Clearer Disclosure of Affiliate Advertising Relationship for Certain Reviews on TrustedCompanyReviews.com
BBB NATIONAL PROGRAMS Through its advertising monitoring program, BBB National Programs' National Advertising Division inquired about the rankings of debt consolidation companies by EIA Marketing on the review website The National Advertising Division (NAD) recommended that the material connection between EIA Marketing and companies listed in reviews that are affiliate partners be more clearly disclosed for certain reviews. New York, NY, July 22, 2025 (GLOBE NEWSWIRE) -- Through its advertising monitoring program, BBB National Programs' National Advertising Division inquired about the rankings of debt consolidation companies by EIA Marketing on the review website The National Advertising Division (NAD) recommended that the material connection between EIA Marketing and companies listed in reviews that are affiliate partners be more clearly disclosed for certain reviews. At issue for NAD was whether the format of the challenged advertising reasonably communicates the implied message that the debt consolidation rankings on the website are independent and objective instead of advertising for the top-rated product. NAD noted that some of the reviews on are those of EIA Marketing's affiliate partners (including the #1 rated debt consolidation company). Even assuming that the partner status of a company did not influence the ranking, NAD found that because TrustedCompanyReviews receives compensation from affiliate partners, the review is not impartial and constitutes advertising for that affiliate partner. NAD was concerned that consumers may not understand, based on the format of the webpage, that they are seeing advertising content for the rated company. NAD determined that the disclosure at the top of the webpage, 'The listings featured on this site are from companies from which this site receives compensation. This influences where, how, and in what order such listings appear on this site,' is not clear and conspicuous. Further, after scrolling down one page, the 'Advertiser Disclosure' is a hover-over disclosure that consumers may miss. NAD also noted that a pop-up advertisement for Accredited Debt Relief obscured the rest of the content on the webpage and referred to its top ranking and an invitation to access its plans. NAD recommended that EIA Marketing:
The Sun
a day ago
- Business
- The Sun
FELCRA should review oil palm plantation acquisitions to ensure good governance - AG's Report
KUALA LUMPUR: The National Audit Department (NAD) has recommended that the acquisition of oil palm plantations under the Federal Land Consolidation and Rehabilitation Authority's (FELCRA) transformation plan be reviewed to ensure investments would bring 'value-for-money' returns based on its financial capabilities. The Auditor-General's Report 2/2025 presented at the Dewan Rakyat today also included recommnedations that the FELCRA Berhad board of directors be responsible in ensuring that oil palm plantation acquisitions were organised in line with their fiduciary duty and good governance practices. Also, the agency was advised to make improvements to its administrative process and that all decisions regarding oil palm plantation acquisitions be made collectively and in line with previous resolutions and the company's constitution. 'Any changes to the board of directors' decisions need to be recorded and confirmation be obtained through a new and clear resolution, with minutes recorded in an organised manner and documented accordingly by the company secretary in line with the Constitution of FELCRA Berhad. 'In addition, FELCRA Berhad also needs to set a minimum timeline between approval and implementation of the agreement to provide room for adequate risk assessment and review,' the report stated. The report also recommended that improvements be made to amendments of the Acquisition Manual that came into effect in September 2024, such as appointment of qualified external consultants to conduct objective due diligence and market value assessments before making any acquisition decisions, and that the consultant's report must be presented to the board of directors as a vital supporting document in investment decisions. Also, a comprehensive study must be conducted to assess financial aspects encompassing break-even points, return on investment, hidden costs, mortgage liabilities and physical rehabilitation needs before finalising any decision. 'Inspection and certification of the status of moveable access need to be conducted before and during the process of vacant possession for oil palm plantations to ensure ownership of the assets as listed in the agreement. 'Verification of physical assets, preparation of a complete asset register of all farm machinery and facilities must also be carried out as stated in the relevant agreement,' the report stated. Auditor-general Datuk Seri Wan Suraya Wan Mohd Radzi issued a statement today stating that there were weaknesses in governance linked to the acquisition of four oil palm plantations by FELCRA Berhad - the Telupid Estate, in Sabah, the Dabong Estate, the Sungai Raiwt 2 Estate and the Aring Estate in Kelantan valued at RM241.76 million between 2022 and 2024. The full AG's Report can be accessed at the following link – Bernama
Yahoo
4 days ago
- Health
- Yahoo
Can you hack aging with NAD supplements?
Walk down the supplement aisle at your local drugstore and you'll likely spot bottles of NAD (nicotinamide adenine dinucleotide) pills, powders, or liquids that promise to slow down aging. The global market for these products hit $535.53 million in 2022. But do NAD supplements really work? 'I get asked about NAD supplements occasionally by patients,' says Dr. Nicholas Dragolea, a London-based GP with an interest in longevity and functional health at My Longevity Centre in the United Kingdom. 'My answer usually is that there isn't enough medical evidence to support taking it.' [ Related: Does drinking collagen actually do anything? ] What is NAD and why the hype? NAD is a molecule your body makes from nutrients in your diet like tryptophan and niacin. It's involved in hundreds of different processes in the body—from metabolism, to brain health, to DNA repair—making it critical for overall human health, explains Daniel Craighead, an assistant professor in the School of Kinesiology at the University of Minnesota Twin Cities. 'NAD levels tend to go down as we get older,' he says. 'Therefore, the thought is that if we can restore NAD through dietary supplements, we may be able to reverse a lot of the signs and symptoms of aging.' [ Related: Is there any truth to anti-aging schemes? ] What do studies show? In 2023, Craighead and his colleagues reviewed research on oral NAD precursors and their effects on healthy aging and age-related chronic diseases. (Rather than NAD itself, many supplements contain NAD precursors like nicotinamide riboside and nicotinamide mononucleotide, which are more stable and are converted to NAD by the body). Lab studies in cells and mice showed promising results, supporting the theory that NAD promotes healthy aging and helps with DNA repair. But human studies paint a more mixed picture. 'So far, most of the studies in people are relatively short, lasting weeks to months, and done in small groups of only a couple dozen people,' says Craighead. 'These human studies have shown that NAD+ precursors are safe and boost NAD+ levels, but significant improvements in health generally haven't been observed.' The best evidence we have is that these NAD precursors may decrease inflammation, adds Craighead. For example, a study published in 2019 found that three weeks of nicotinamide riboside supplementation reduced blood markers of inflammation by 50% to 70% in older men. Chronic inflammation is a hallmark of aging and age-related diseases, making this a promising result. Another review, published in 2024, noted potential benefits for age-related and neurological conditions like Parkinson's and Alzheimer's disease, but cautioned that further clinical trials must be performed. One of the studies included in the review showed that oral nicotinamide riboside supplements increased brain NAD levels and altered brain metabolism in individuals with Parkinson's disease. The supplements also reduced inflammatory cytokines—proteins that act as messengers in the immune system—in the blood and cerebrospinal fluid (a fluid that surrounds and protects the brain and spinal cord) of participants. In another 2004 study, patients with Alzheimer's disease who took NAD supplements showed improvements in cognitive functions, such as verbal fluency and abstract reasoning. What do doctors say? Some clinicians report anecdotal benefits. 'My patients see huge improvements in energy when I start them on injections of daily low dose NAD,' says Dr. Heather Hinshelwood, the co-owner and chief of medicine of Fraum Health, a provider of restorative medicine, chiropractic, and proactive wellness care on Hilton Head Island in South Carolina. 'I have dementia patients who start having better cognition than their spouses,' she adds. But many experts remain cautious.'There is no high-quality evidence that NAD supplementation has any health benefit,' says Dr. David S. Seres, a professor of medicine at the Institute of Human Nutrition at Columbia University Medical Center in New York. 'Without strong evidence from well-done randomized trials, we recommend against taking any dietary supplements.' Are they safe? So far, human studies indicate that NAD supplements are generally safe. But Dr. Seres warns that safety assumptions based on weak evidence can be dangerous. Take vitamin E and selenium: Early research showed that men with prostate cancer had low levels of vitamin E and selenium. But a clinical trial involving 35,000 men later found that men who took vitamin E were more likely to develop prostate cancer compared to men on placebo. 'You cannot assume that supplements are effective or safe based on the kind of evidence used to make claims such as 'supports energy' or 'supports healthy aging,'' says Seres. [ Related: 7 things you can do to actually prevent wrinkles ] Bottom line For now, NAD supplements are not a proven tool for healthy aging. 'Longer studies with more participants are needed,' says Craighead. If you still want to try taking NAD, just note that not all supplements contain what their labels claim. A 2024 analysis found that many nicotinamide mononucleotide (NMN) products contained far less of the active ingredient than advertised, Craighead says, 'so consumers may be wasting money on supplements that contain no NMN.' This story is part of Popular Science's Ask Us Anything series, where we answer your most outlandish, mind-burning questions, from the ordinary to the off-the-wall. Have something you've always wanted to know? Ask us.
Los Angeles Times
6 days ago
- Health
- Los Angeles Times
Robert Fried Says Niagen Bioscience Has the Key to Better Aging, and He Has the Science to Prove It
In a recent interview, Robert Fried, CEO of Niagen Bioscience, delves into the science of aging and the pivotal role of a molecule known as NAD (nicotinamide adenine dinucleotide). He explains how NAD is crucial for cellular energy and repair, and how its decline with age contributes to a slower recovery from injuries and the progression of age-related conditions. Fried clarifies a common misconception: NAD itself is not bioavailable when taken orally. Instead, he highlights the importance of a precursor molecule, nicotinamide riboside, which is readily absorbed by cells and converted into NAD. Niagen Bioscience's flagship product, Niagen, is a patented and extensively researched form of nicotinamide riboside. A significant concern for Fried is the lack of integrity in the broader dietary supplement market. He cites a study where less than 1% of competing NAD-boosting products met their label claims, with 40% containing none of the active ingredient. He contrasts this with Niagen Bioscience's commitment to rigorous scientific research, evidenced by 38 peer-reviewed human clinical studies and over 100 preclinical studies. Fried emphasizes that Niagen Bioscience is not just another supplement company. They are singularly focused on NAD and its potential therapeutic benefits. A major four-and-a-half-year study on Parkinson's disease, involving 400 participants, is nearing completion and is expected to provide further evidence of Niagen's potential to address serious age-related diseases. The company's mission, according to Fried, is to educate the public about the importance of NAD and to establish Niagen as the 'gold standard' in the NAD space. He stresses that Niagen is the only patented, legal, and trusted form of nicotinamide riboside, backed by unparalleled scientific research.
Yahoo
14-07-2025
- Business
- Yahoo
Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York
Both Tru Niagen, featured as the newest in-room offering for hotel guests, and Niagen IV, available at NutriDrip's location at The Spa by Equinox Hotel New York, support cellular energy production and DNA repair for optimal recovery LOS ANGELES, July 14, 2025--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the inaugural hotel debut of Tru Niagen® as an in-room amenity at the Equinox Hotel New York, and Niagen IV, now available at the hotel's spa through NutriDrip. Rob Fried, CEO of Niagen Bioscience, remarked, "Our partnership with Equinox Hotel and NutriDrip underscores our commitment to growing consumer access, driving brand strength, and capturing new market opportunities for our flagship Niagen products." Equinox Hotels, a luxury hospitality brand built on the evolution of Equinox, has been thoroughly conceptualized and brought to life to translate a high-performance lifestyle into a seamless guest experience through cutting-edge and science-backed fitness, recovery, and nutrition services. Hotel guests can now experience the transformative cellular health benefits of Tru Niagen, the number one healthy-aging NAD+ supplement in the United States†, with bottles available as the newest in-room offering. Additionally, the groundbreaking pharmaceutical-grade product, Niagen IV, is available at The Spa by Equinox Hotel New York through NutriDrip. Angela Portella, Director of Spa at Equinox Hotel, commented, "At Equinox Hotels, we provide our community with the highest quality, science-backed products and services. Tru Niagen, recognized as the gold-standard NAD+-boosting supplement, and NutriDrip, the best in the IV therapy business, reflect our mission." Tru Niagen and Niagen IV are powered by Niagen Bioscience's clinically proven flagship ingredient, Niagen® (patented nicotinamide riboside or NR), the most efficient, well-researched, and high-quality NAD+ booster available. NAD+ is a vital coenzyme found in every cell of the human body that supports cellular energy production and DNA repair to support recovery. Asa Kitfield, Managing Partner at Clean Market & NutriDrip, remarked, "We are thrilled to offer Niagen IV at our premium Equinox Hotel New York location. This cutting-edge infusion represents a profound advancement for elevating NAD+ intravenously. It's a game-changer for muscle health and recovery." About Tru Niagen and Niagen IV Tru Niagen is backed by the highest scientific and quality standards, including a Nobel Prize winner, 35+ human clinical studies, 400+ published scientific studies, and has been accepted by the world's most rigorous regulatory bodies. All Tru Niagen products are third-party certified, with Tru Niagen Pro 1,000mg and Tru Niagen Stick Packs NSF Certified for Sport, ensuring their safety, quality, and integrity for elite athletes and fitness enthusiasts alike. Niagen IV represents a significant advancement in intravenous NAD+-boosting therapy. NAD+ IV has gained popularity amongst doctors, fitness experts, celebrities, and athletes because of the substantial benefits, but the experience can be unpleasant. In a head-to-head comparison with NAD+ IV, Niagen IV offered superior tolerability, a 75% shorter infusion time, and resulted in a statistically significant 20% increase in whole blood NAD+ levels three hours post-infusion (MedRxiv). For additional information on the science supporting Niagen, visit Learn more about Equinox Hotel New York at and NutriDrip at About Niagen Bioscience: Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There's a better way to age. At the heart of its clinically proven product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, high-quality, and legal NAD+ booster available. Niagen powers the Company's consumer supplement, Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (available at and Niagen Plus™, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products ( Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. Niagen Bioscience's robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at where copies of press releases, news, and financial information are regularly published. †Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 1/1/2024 - 12/31/2024). About Equinox Hotels Equinox Hotels is a rapidly expanding, global luxury hospitality brand and management company built off the evolution of Equinox. With a design-forward perspective and 360-approach to luxury lifestyle, our portfolio spans urban, resort, and destination locations globally set in architecturally stunning spaces built for high-performance living. Only Equinox Hotels can seamlessly integrate a hotel experience with an existing community of engaged, loyal members who activate the Clubs daily. Equinox Branded Residences offer lifestyle, status, and the notion of health associated with the Equinox brand and global membership. Equinox Hotels has a robust global pipeline that is defining a new category of luxury. For more information on Equinox Hotels please visit: About NutriDrip As a leader in functional wellness, NutriDrip provides IV Nutrient Therapy for therapeutic and rejuvenating benefits with a full menu of signature Wellness and Recovery IV Drips. Traditional oral supplementation is hard for your body to absorb and results are slow, while IV Nutrient Therapy provides 100% bioavailability for fast-acting results. NutriDrip's signature IV Drips, which are administered by nurse practitioners and registered nurses, utilize fluids, electrolytes, vitamins and minerals to help you feel & function better. Knowing that we all have different health and nutritional needs, NutriDrip takes a personalized approach to wellness with a best-in-class medical team that will help select and customize the right IV Drip protocol for you. Forward Looking Statements: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, including statements related to infringement or non-infringement of intellectual property rights. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential," "possible," "probable," "believes," "seeks," "may," "will," "should," "could" or the negative of such terms or other similar expressions. Risks that contribute to the uncertain nature of these forward-looking statements include our history of operating losses and need to obtain additional financing; the growth and profitability of our product sales; our ability to maintain sales, marketing and distribution capabilities; changing consumer perceptions of our products; our reliance on a single or limited number of third-party suppliers; and the risks and uncertainties associated with our business and financial condition. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and Niagen Bioscience undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof. View source version on Contacts Niagen Bioscience Media Contact: Kendall Knysch, Senior Director of Media Relations & Niagen Bioscience Investor Relations Contact: ICR, LLCReed Anderson(646) 277-1260Stephanie Carrington(646) 277-1282niagenir@ Equinox Hotels Media Contact: Caroline McKayCaroline@
